Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Lymphoid Interstitial Pneumonia 1Breast Neoplasms 1

Interventions

Cisplatin 4Platinum 3Cetuximab 31,2-diaminocyclohexaneplatinum II citrate 3Immunoglobulin G 2Fluorouracil 2Docetaxel 2Disulfides 2Carboplatin 2Bevacizumab 2temsirolimus 1dl1520 1dehydroftorafur 1cediranib 1atezolizumab 1adavosertib 1Specimen Handling 1Soybean Proteins 1Sirolimus 1Magnetic Resonance Spectroscopy 1Lenalidomide 1(225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Lymphoid Interstitial Pneumonia × Soybean Proteins × Clear all
NCT02007200 2016-10-24

Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery

National Cancer Institute (NCI)

Phase 2 Completed
55 enrolled 8 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡